{
  "id": 20491038,
  "title": "Beren wins FDA approval for long-studied rare disease drug",
  "url": "https://urgent.news/2026/11/17/beren-wins-fda-approval-for-long-studied-rare-disease-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T20:25:23.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/beren-wins-fda-approval-for-long-studied-rare-disease-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A molecule designed by government scientists more than a decade ago has won FDA approval to treat infantile-onset Niemann-Pick disease type C, capping a winding and rocky development path. Beren Therapeutics, developer of Lembaz (adrabetadex) ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}